Memphis Pharmaceuticals (MPCI)

Last update: 15 July 01:29 PM market time.

244.76

118.76

94.07%

Open 245.01

Previous Close 126.25

High 248.98

Low 243.00

Stock Statistics

Volume 466,845

Turnover 115,397,568.00

All data are 15 minutes late during market session

News

Photo Archive

16 October 2022 10:39 AM Memphis Pharmaceutical’s shareholders approve company’s continuity

Cairo – Mubasher: The extraordinary general assembly (EGM) of Memphis Pharmaceutical and Chemical Industries has approved the continuity of the company’s activity, during a meeting held on Thursday, 13 October 2022. In the meantime, the company’s …

General Assembly

Photo Archive

2 October 2022 01:22 PM Memphis Pharmaceutical’s board approves capital raise

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries’ board of directors approved increasing the company’s issued and paid-up capital to EGP 227.50 million from EGP 56.25 million. The capital hike includes Holding Co for …

Companies Investments

Photo Archive

14 September 2022 00:21 PM Memphis Pharmaceutical approves financing to pay off EGP 300m debt

Cairo – Mubasher: The board of directors of Memphis Pharmaceutical and Chemical Industries has approved by circulation the financing package provided by the Abu Dhabi Islamic Bank (ADIB) to pay off a debt worth EGP 300 million. The debt is owed by …

Companies Investments

Photo Archive

11 September 2022 11:04 AM Memphis Pharmaceutical’s annual profits climb 77%

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries’ adjusted financial statements for fiscal year (FY) 2021/2022 indicated a 77% annual hike in profits. Earnings of the EGX-listed firm amounted to EGP 74.08 million during the period …

Financial Results

Photo Archive

9 June 2022 04:10 PM Memphis Pharmaceutical targets EGP 50m profits in FY22/23

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries plans to achieve net profits before tax worth EGP 50 million in fiscal year (FY) 2022/2023, compared to its target of EGP 43 million for FY21/22. The company generated EGP 41.65 …

Financial Results

Photo Archive

15 March 2022 00:45 PM Memphis Pharmaceutical to obtain financing from ADIB

Cairo – Mubasher: The board of Memphis Pharmaceutical and Chemical Industries has approved to obtain financing packages from Abu Dhabi Islamic Bank (ADIB). Through the facility, the company will pay off its debt owed to El Gomhouria …

Companies Investments

Photo Archive

26 January 2022 01:45 PM Memphis Pharmaceutical's board approves capital raise to EGP 241m

Cairo – Mubasher: The board of Memphis Pharmaceutical and Chemical Industries has approved a rise in the issued and paid-up capital to EGP 241.25 million from EGP 56.25 million. The capital increase includes Holding Co for Pharmaceuticals' 60% …

Companies Investments

Abla Youssef Abdullah was named the Managing Director

7 June 2021 03:06 PM Essam Sadek named Chairman of Memphis Pharmaceutical

Cairo – Mubasher: The board of directors of Memphis Pharmaceutical and Chemical Industries approved the appointment of Essam Sadek Mohamed Sadek as the company’s Non-Executive Chairman. The board also named Abla Youssef Abdullah as the Managing …

Board of Directors

The company's revenues increased by 9.9%

30 May 2021 03:16 PM Memphis Pharmaceutical posts 558% higher profits in 10M

Cairo – Mubasher: The net profits of Memphis Pharmaceutical and Chemical Industries have hiked by 558% to EGP 34.18 million in the first ten months of fiscal year (FY) 2020/2021, compared to EGP 5.2 million in the year-ago period. The company's …

Financial Results

The company’s revenues increased to EGP 395.5 million

21 April 2021 11:52 AM Memphis Pharmaceutical's profit hikes 386% in nine months

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries posted a 386% leap in its net profits, registering EGP 25.37 million in the first nine months of fiscal year (FY) 2020/2021, compared to EGP 5.22 million in the year-ago period, the …

Financial Results

The company’s revenues grew to EGP 360.32 million

24 March 2021 01:37 PM Memphis Pharmaceutical's pretax profit jumps 480% in eight months

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries recorded a 480% year-on-year (YoY) surge in its net profits before taxes, logging EGP 23.73 million during the first eight months of fiscal year 2020/2021, compared to EGP 4.09 …

Financial Results

Revenues rose to EGP 267.86 million in the July-December period

20 January 2021 01:03 PM Memphis Pharmaceutical’s pretax profit jumps 463% in H1-20/21

Cairo – Mubasher: The unaudited financial results of Memphis Pharmaceutical and Chemical Industries showed net profits before taxes of EGP 18.81 million in the first half (H1) of fiscal year 2020/2021, up by 463% year-on-year (YoY) from EGP 3.34 …

Financial Results

The company achieved net profits of EGP 12.4 million in FY19/20

26 August 2020 01:33 PM Egypt’s FRA approves Memphis Pharmaceutical’s EGP 200m capital raise

Cairo – Mubasher: Egypt’s Financial Regulatory Authority (FRA) approved to publish the disclosure form of Memphis Pharmaceutical and Chemical Industries to proceed in raising its authorised capital. The disclosure form includes the board of …

Management Decisions

Revenues rose to EGP 114.63 million

23 October 2019 01:12 PM Memphis Pharmaceutical's unaudited Q1-19/20 financials turn positive

Cairo – Mubasher: the unaudited financial results of Memphis Pharmaceutical and Chemical Industries showed a net profit of EGP 1.17 million in the first quarter of fiscal year 2019/2020, against a loss of EGP 12.93 million in the prior-year …

Financial Results

Revenues rose to EGP 366.8 million

9 September 2019 00:10 PM Memphis Pharmaceutical’s losses shrink 46% in FY18/19

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries reported a 45.7% year-on-year decrease in its losses during fiscal year 2019/2019. The company suffered losses after taxes of EGP 25.37 million in FY18/19, compared to EGP 46.73 …

Financial Results

Revenues amounted to EGP 367.7 million in FY18/19

28 July 2019 11:36 AM Memphis Pharmaceutical's FY18/19 unaudited financials show EGP 18m loss

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries reported a 61.5% year-on-year decline in its losses during fiscal year 2018/2019, according to the company's unaudited financial results. The company incurred net losses after taxes …

Financial Results

Losses before taxes stood at EGP 16.31 million

16 June 2019 04:00 PM Memphis Pharmaceutical’s losses drop 57% in 11M

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries reported a 56.6% year-on-year retreat in its losses during the first 11 months of fiscal year 2018/2019, the company’s board of directors said. The pharmaceuticals firm’s losses …

General Assembly

Losses after taxes stood at EGP 16.29 million

19 May 2019 01:32 PM Memphis Pharmaceutical narrows losses by 52% in 10M

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries reported a 52.1% year-on-year decline in its losses during the first 10 months of fiscal year 2018/2019, the company’s board of directors said. The pharmaceuticals firm’s losses …

Financial Results

Memphis Pharmaceutical's sales reached EGP 281 million in the nine-month period ended last March

14 April 2019 01:21 PM Memphis Pharmaceutical’s losses decline 45% in 9M

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries has suffered EGP 16.9 million in losses for the first nine months of fiscal year 2018/2019, down 44.9% year-on-year from EGP 30.7 million, according to a statement on Sunday. The …

Financial Results

The OGM also endorsed the investment plan for FY19/20

1 April 2019 03:39 PM Memphis Pharmaceutical OKs FY19/20 estimated budget

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries’ ordinary general meeting (OGM) on Monday announced approving the estimated budget for fiscal year 2019/2020. The OGM also endorsed the investment plan for FY19/20, according to a …

Management Decisions

The company suffered EGP 16.5 million in loss during the July-February period of FY18/19

17 March 2019 03:45 PM Memphis Pharmaceutical trims loss to EGP 16.5m in 8M

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries on Sunday posted a 32.9% year-on-year decline in its losses for the first eight months of fiscal year 2018/2019. The company suffered EGP 16.5 million in loss during the …

Financial Results

Net losses amounted to EGP 18 million in H1-17/18

27 January 2019 04:12 PM Memphis Pharmaceuticals losses slip 9% in 6M

Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries on Sunday posted a 9% year-on-year decrease in its profits for the first half of fiscal year 2017/2018. Net losses amounted to EGP 18 million in H1-17/18, versus EGP 19.79 million in …

Financial Results

Net losses amounted to EGP 22.85 million in the year ended September

8 October 2018 04:46 PM Memphis Pharmaceuticals widens losses in FY18

Cairo – Mubasher: Memphis Pharmaceuticals and Chemical Industries on Monday said its losses surged by 188.1% year-on-year in the fiscal year ended 30 September 2018. Net losses amounted to EGP 22.85 million in the year ended September, up from EGP …

Financial Results

Memphis Pharmaceutical turns to losses in 5M

10 December 2017 00:38 PM Memphis Pharmaceutical turns to losses in 5M

Cairo – Mubasher: Egypt-based Memphis Pharmaceutical and Chemical Industries (MPCI) turned to losses year-on-year during the first five months of the fiscal year 2017/2018. The company’s losses amounted to EGP 14.9 million from July until November …

Financial Results

Sales decreased to EGP 248.2 million in FY16/17

30 July 2017 08:38 PM Memphis Pharmaceutical turns to losses in FY16/17

Cairo - Mubasher: Memphis Pharmaceutical and Chemical Industries (MPCI) posted losses of EGP 21.1 million for fiscal year 2016/2017 against profits of EGP 89,000 in the year before, as shown by the company’s financial indicators. The company said …

Financial Results